Evidence map›Paper›PMID 34233347›Full record

ArticlePLoS computational biology2021

Average beta burst duration profiles provide a signature of dynamical changes between the ON and OFF medication states in Parkinson's disease.

Benoit Duchet, Filippo Ghezzi, Gihan Weerasinghe, Gerd Tinkhauser, Andrea A Kühn, Peter Brown, Christian Bick, Rafal Bogacz

Abstract read
In one paragraph

Article in PLoS computational biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Review
  3. Article
  4. Brain-computer interface-based neurofeedback training enables transferable control of cortical state switching in humans.Proceedings of the National Academy of Sciences of the United States of America · 2026
    Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Prediction of Pathological Subthalamic Nucleus Beta Burst Occurrence in Parkinson's Disease.Movement disorders : official journal of the Movement Disorder Society · 2025
    Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Bursting with Potential: How Sensorimotor Beta Bursts Develop from Infancy to Adulthood.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2023
    Article
  17. Clinical neurophysiological interrogation of motor slowing: A critical step towards tuning adaptive deep brain stimulation.Clinical neurophysiology : official journal of the International Federation of Clinical Neurophysiology · 2023
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Benoit DuchetNuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.ORCID 0000-0001-6147-905X
Filippo GhezziDepartment of Physiology, Anatomy, and Genetics, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-4538-2578
Gihan WeerasingheNuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.ORCID 0000-0003-0712-1596
Gerd TinkhauserDepartment of Neurology, Bern University Hospital and University of Bern, Bern, Switzerland.ORCID 0000-0002-1954-1873
Andrea A KühnCharité - Universitätsmedizin Berlin, Department of Neurology, Movement Disorder and Neuromodulation Unit, Berlin, Germany.
Peter BrownNuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-5201-3044
Christian BickDepartment of Mathematics, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0002-5238-1146
Rafal BogaczNuffield Department of Clinical Neuroscience, University of Oxford, Oxford, United Kingdom.ORCID 0000-0002-8994-1661

Funding

Medical Research Council MC_UU_00003/1Medical Research Council MC_UU_12024/1Medical Research Council MC_UU_12024/5Wellcome Trust
6 · The paper itself

Abstract

Parkinson's disease motor symptoms are associated with an increase in subthalamic nucleus beta band oscillatory power. However, these oscillations are phasic, and there is a growing body of evidence suggesting that beta burst duration may be of critical importance to motor symptoms. This makes insights into the dynamics of beta bursting generation valuable, in particular to refine closed-loop deep brain stimulation in Parkinson's disease. In this study, we ask the question "Can average burst duration reveal how dynamics change between the ON and OFF medication states?". Our analysis of local field potentials from the subthalamic nucleus demonstrates using linear surrogates that the system generating beta oscillations is more likely to act in a non-linear regime OFF medication and that the change in a non-linearity measure is correlated with motor impairment. In addition, we pinpoint the simplest dynamical changes that could be responsible for changes in the temporal patterning of beta oscillations between medication states by fitting to data biologically inspired models, and simpler beta envelope models. Finally, we show that the non-linearity can be directly extracted from average burst duration profiles under the assumption of constant noise in envelope models. This reveals that average burst duration profiles provide a window into burst dynamics, which may underlie the success of burst duration as a biomarker. In summary, we demonstrate a relationship between average burst duration profiles, dynamics of the system generating beta oscillations, and motor impairment, which puts us in a better position to understand the pathology and improve therapies such as deep brain stimulation.

Indexed as

Antiparkinson AgentsBeta RhythmComputational BiologyHumansModels, NeurologicalParkinson DiseaseSubthalamic NucleusAntiparkinson Agents

Identifiers

PMID34233347
PMCPMC8263069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.